Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ISRCTN50841639) titled 'How bevacizumab affects gum and mouth healing after tooth extraction in cancer patients in central Algeria' on July 31.
Study Type: Interventional
Study Design:
Allocation: Non-randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: University of Blida
Condition:
Cancer or malignant tumors requiring tooth extraction in patients undergoing antineoplastic treatments (bevacizumab and/or conventional chemotherapy).
Cancer
Intervention:
This study is a comparative, prospective, multicenter interventional study. Baseline data were collec...